Origin

Princeton, United States

Origin is a privately-held, clinical-stage biotechnology company developing a medical technology to deliver therapeutic molecules.

$51K raised

Oct 2023

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Origin raised?

Origin has raised $51K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.

Who are Origin's investors?

Origin's investors include Techstars.

Where is Origin headquartered?

Origin is headquartered in Princeton, United States.

What does Origin do?

Origin is a privately-held, clinical-stage biotechnology company developing a medical technology to deliver therapeutic molecules.

What stage is Origin at?

Origin is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 17, 2023.

MLA

"Origin — Funding & Investors." VCBacked, October 17, 2023, https://www.vcbacked.co/company/origin. Accessed July 8, 2026.

APA

VCBacked. (2023). Origin — Funding & Investors. Retrieved July 8, 2026, from https://www.vcbacked.co/company/origin

Wikipedia (cite web)

{{cite web |title=Origin — Funding & Investors |url=https://www.vcbacked.co/company/origin |website=VCBacked |access-date=July 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 17, 2023.